FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review.

Abdel-Aziz, Amal Kamal; Dokla, Eman M E; Saadeldin, Mona Kamal

Abdel-Aziz, Amal Kamal; Dokla, Eman M E; Saadeldin, Mona Kamal.

Afiliación

Abdel-Aziz AK; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt; Smart Health Initiative, Biological and Environmental Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia. Electronic address: AmalAbdel-Aziz@pharma.asu.edu.eg.
Dokla EME; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
Saadeldin MK; Department of Chemical and Biomolecular Engineering, University of Notre Dame, Leahy Drive, Notre Dame, IN 46556, USA.

Crit Rev Oncol Hematol ; 191: 104139, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37717880

Palabras clave

AML; Biomarker; Drug interaction; FLT3 mutation; Resistance; Toxicity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Crit Rev Oncol Hematol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google